drugset
drugset / Trial / NCT06603766

Treatment of Persistent Pulmonary Hypertension in Neonates With Nebulized Magnesium Sulfate

NCT06603766 ↗

Phase 2/3 Completed 40 enrolled Benha University
Non-randomizedParallel-groupOpen-labelTreatment

Summary

we conducted this study to compare between effect of nebulized and intravenous magnesium sulfate (MgSO₄) for better treatment of persistent pulmonary hypertension of neonates with less side effects.

Timeline

Start
2021-10-01
Primary completion
2023-09-28
Completion
2023-09-28

Drugs

EvaluationDrugModalityDoseRoute
Comparator Magnesium Sulfate Other / unclassified 50 mg/kg Intravenous
Comparator Magnesium Sulfate Other / unclassified 256 mg Intravenous

Indications

No indication recorded.